Vik Chopra

Stock Analyst at BMO Capital

(2.49)
# 3,067
Out of 4,673 analysts
218
Total ratings
45.5%
Success rate
1.8%
Average return

Stocks Rated by Vik Chopra

Solventum
Aug 17, 2026
Maintained: Hold
Price Target: $84
Current: $89.57
Upside: -6.22%
Align Technology
Aug 12, 2026
Maintained: Buy
Price Target: $209
Current: $162.55
Upside: +28.58%
Enovis
Aug 7, 2026
Maintained: Buy
Price Target: $29$30
Current: $26.06
Upside: +15.12%
Globus Medical
Aug 7, 2026
Reiterated: Buy
Price Target: $94
Current: $86.91
Upside: +8.16%
DENTSPLY SIRONA
Aug 6, 2026
Maintained: Hold
Price Target: $12$13
Current: $10.92
Upside: +19.05%
Zimmer Biomet Holdings
Aug 6, 2026
Maintained: Hold
Price Target: $95$96
Current: $100.98
Upside: -4.93%
Alphatec Holdings
Aug 5, 2026
Rated: Buy
Price Target: $11$12
Current: $9.48
Upside: +26.58%
Envista Holdings
Aug 5, 2026
Maintained: Hold
Price Target: $27$29
Current: $27.20
Upside: +6.62%
Henry Schein
Aug 4, 2026
Maintained: Hold
Price Target: $85
Current: $88.50
Upside: -3.95%
Stryker
Jul 31, 2026
Maintained: Buy
Price Target: $369
Current: $329.45
Upside: +12.00%
Maintained: Hold
Price Target: $19$18
Current: $16.74
Upside: +7.53%
Maintained: Hold
Price Target: $70$71
Current: $74.82
Upside: -5.11%
Maintained: Hold
Price Target: $36$45
Current: $51.07
Upside: -11.89%
Maintained: Buy
Price Target: $518
Current: $378.81
Upside: +36.74%
Initiated Coverage: Buy
Price Target: $159
Current: $138.83
Upside: +14.53%
Maintained: Buy
Price Target: n/a
Current: $92.82
Upside: -
Reiterated: Buy
Price Target: $15$19
Current: $14.03
Upside: +35.42%
Reiterated: Buy
Price Target: $109
Current: $89.79
Upside: n/a